Immune Checkpoint Inhibition Trials in MCC: Advanced ... · Presented By Selma Ugurel at 2018 ASCO Annual Meeting . ... Slides are the property the required reuse. Immune Checkpoint
Post on 22-Jun-2020
2 Views
Preview:
Transcript
Immune Checkpoint Inhibition Trials in MCC:<br />Advanced Metastatic Disease
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Immune Checkpoint Inhibition Trials in MCC:<br />Advanced Metastatic Disease
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Overall survival with pembrolizumab for MCC <br />
Presented By Paul Nghiem at 2018 ASCO Annual Meeting
Anti-PD-1/PD-L1 in advanced MCC: <br />first-line or second-line (chemo-naïve or chemo-pretreated) ?
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Anti-PD-1/PD-L1 in advanced MCC: <br />first-line or second-line (chemo-naïve or chemo-pretreated) ?
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Durable response on anti-PD-1/PD-L1 ?
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Which patterns of resistance do we see ?
Presented By Selma Ugurel at 2018 ASCO Annual Meeting
Radiologic tumor response to pembrolizumab in patients<br />per viral status<br /><br /><br />
Presented By Paul Nghiem at 2018 ASCO Annual Meeting
top related